| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $228,059,154 ) (Continued on the next page) |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA248981 | Developing and Testing a Digital Toolkit to Improve Colorectal Cancer Screening Rates in Federally Qualified Health Centers | 001 | 5 | NIH | 5/22/2025 | $66,533 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA248981 | Developing and Testing a Digital Toolkit to Improve Colorectal Cancer Screening Rates in Federally Qualified Health Centers | 000 | 5 | NIH | 3/19/2025 | $598,792 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL173318 | Mechanisms of de novo cardiac sarcomere assembly | 000 | 2 | NIH | 3/14/2025 | $600,471 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA271604 | Modeling Best Approaches for Cardiovascular Disease Prevention in Cancer Survivors | 000 | 3 | NIH | 3/4/2025 | $628,104 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K08HL173639 | Precision Prediction of Right Ventricular Size, Function, and Outcomes in Patients with Repaired Tetralogy of Fallot | 000 | 1 | NIH | 2/24/2025 | $167,588 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH124839 | 3/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact | 000 | 5 | NIH | 2/14/2025 | $301,273 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS127442 | The Role of Core Circadian Regulator Bmal1 in Axonal Regeneration and Nerve Repair | 000 | 3 | NIH | 2/14/2025 | $502,613 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HG013350 | Systematic integration of variant interpretation tools into genetic and genomic risk prediction | 001 | 2 | NIH | 4/24/2025 | $60,141 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HG013350 | Systematic integration of variant interpretation tools into genetic and genomic risk prediction | 000 | 2 | NIH | 2/14/2025 | $541,262 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG087324 | Leveraging large-scale genomics to dissect A-to-I editing in brain aging and Alzheimer's disease | 000 | 2 | NIH | 2/14/2025 | $508,112 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DA051191 | Molecular Neurobiology of Human Opioid Use Disorder | 001 | 5 | NIH | 4/11/2025 | $58,639 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DA051191 | Molecular Neurobiology of Human Opioid Use Disorder | 000 | 5 | NIH | 3/17/2025 | $527,758 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA260711 | Impact of mutational order on molecular mechanisms of oncogenesis | 001 | 4 | NIH | 5/23/2025 | $64,801 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA260711 | Impact of mutational order on molecular mechanisms of oncogenesis | 000 | 4 | NIH | 2/17/2025 | $583,211 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL173456 | Microfluidic organoid model of cardio-hepatic physiology and disease | 000 | 2 | NIH | 3/11/2025 | $495,329 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R50CA276021 | NCI Research Specialist (Clinician Scientist) Award | 000 | 3 | NIH | 3/18/2025 | $91,123 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K08HL163489 | The Role of PPM1D in Myeloproliferative Neoplasms | 000 | 3 | NIH | 3/10/2025 | $164,404 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31CA280993 | Merkel cell polyomavirus T-Antigen mediated reprogramming in adult epidermis | 001 | 2 | NIH | 5/22/2025 | $564 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31CA280993 | Merkel cell polyomavirus T-Antigen mediated reprogramming in adult epidermis | 000 | 2 | NIH | 3/3/2025 | $47,374 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA269954 | HLA-E and NKG2A define a novel immune checkpoint axis in non-muscle-invasive bladder cancer | 001 | 3 | NIH | 5/22/2025 | $66,717 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA269954 | HLA-E and NKG2A define a novel immune checkpoint axis in non-muscle-invasive bladder cancer | 000 | 3 | NIH | 2/14/2025 | $600,457 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH118297 | Maturation of frontal cortico-thalamic circuitry in control of social behavior | 002 | 7 | NIH | 3/27/2025 | $565,819 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK138369 | The KQ1 serum study: soluble biomarkers for T1D risk, development & progression | 000 | 2 | NIH | 2/14/2025 | $1,095,529 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH123069 | Neural, computational and behavioral characterization of dynamic social behavior in borderline and avoidant personality disorder | 000 | 5 | NIH | 2/14/2025 | $496,629 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH129372 | Functional mapping of noncoding regulatory variants in human neuronal subtypes3. | 000 | 4 | NIH | 2/14/2025 | $543,751 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG084699 | Intranasal delivery of VGF-derived peptides in a preclinical model of Alzheimer's disease | 000 | 2 | NIH | 2/14/2025 | $760,250 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA269382 | POTENTIATION OF ANTI-TUMOR IMMUNITY BY ONCOLYTIC VIRUS IN SITU VACCINATION | 003 | 4 | NIH | 5/22/2025 | $61,109 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA269382 | POTENTIATION OF ANTI-TUMOR IMMUNITY BY ONCOLYTIC VIRUS IN SITU VACCINATION | 002 | 4 | NIH | 3/10/2025 | $549,977 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL173203 | The Chromatin Remodeling Factor ARID1a and the Epigenetic Landscape In Pulmonary Arterial Hypertension | 000 | 2 | NIH | 2/19/2025 | $755,295 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK139631 | Nrf2 and the expansion and preservation of beta cell mass | 000 | 2 | NIH | 2/21/2025 | $662,227 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | T32GM082773 | T32 training grant in medical genetics. | 003 | 16 | NIH | 6/24/2025 | $193,858 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F32AG082483 | Investigating the role of an EIF2B3 variant as an Alzheimer's disease risk modifier | 001 | 3 | NIH | 6/23/2025 | $1,284 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F32AG082483 | Investigating the role of an EIF2B3 variant as an Alzheimer's disease risk modifier | 000 | 3 | NIH | 3/12/2025 | $79,756 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA290438 | Artificial intelligence enabled Stroma-Weighted Automated Grading system to improve risk stratification in Black Men | 000 | 1 | NIH | 3/12/2025 | $717,667 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK112978 | The Influence Of Gut Microbiota Stability In Inflammatory Bowel Disease | 002 | 7 | NIH | 6/11/2025 | $64,146 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK112978 | The Influence Of Gut Microbiota Stability In Inflammatory Bowel Disease | 000 | 7 | NIH | 3/5/2025 | $577,304 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01EY037134 | Nicotinic modulation of deep layer somatostatin interneurons for visual critical period plasticity | 000 | 1 | NIH | 3/13/2025 | $562,660 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK139395 | Genetic risk and molecular characterization of Diabetic Kidney Disease | 001 | 2 | NIH | 5/21/2025 | $33,799 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK139395 | Genetic risk and molecular characterization of Diabetic Kidney Disease | 000 | 2 | NIH | 3/4/2025 | $304,201 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HD102614 | FUNCTIONAL CHARACTERIZATION OF NOVEL DETERMINANTS OF HOLOPROSENCEPHALY (HPE) | 001 | 5 | NIH | 5/1/2025 | $36,335 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HD102614 | FUNCTIONAL CHARACTERIZATION OF NOVEL DETERMINANTS OF HOLOPROSENCEPHALY (HPE) | 000 | 5 | NIH | 2/19/2025 | $327,015 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL171695 | Comprehensive Patient-centered Home-based care coaching for COPD self-management | 000 | 2 | NIH | 2/26/2025 | $610,261 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01DA053629 | Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice | 001 | 5 | NIH | 4/8/2025 | $164,155 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01DA053629 | Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice | 000 | 5 | NIH | 2/26/2025 | $1,477,403 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA274251 | Investigating the Molecular Determinants Driving Response and Resistance to HDAC6 Targeted Therapy in Breast Cancer | 001 | 2 | NIH | 5/22/2025 | $56,919 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA274251 | Investigating the Molecular Determinants Driving Response and Resistance to HDAC6 Targeted Therapy in Breast Cancer | 000 | 2 | NIH | 2/12/2025 | $512,262 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31NS134301 | Theta Phase-Locked Stimulation of Entorhinal-Hippocampal Inputs in Healthy and Epileptic Mice | 000 | 2 | NIH | 3/14/2025 | $47,374 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH139952 | Moderate effect size genes in autism spectrum disorder | 000 | 1 | NIH | 6/18/2025 | $844,917 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01AI181883 | Mount Sinai's CoFAR Clinical Research Center | 000 | 2 | NIH | 2/12/2025 | $399,999 |
|
